Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation

TEMECULA, Calif. - EntSun -- Jellyfish Publication-Certified Nutraceuticals, Inc.

Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.

Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025

Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.

The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.

More on EntSun News

• Jeopardy!'s Ken Jennings Headlines National Mensa Event
• Mensa Foundation Prize Awarded to Neuroscientist-Pianist
• New book, "High-Tech Heroes," redefines billionaire as someone who improves a billion lives
• From Marvel to Meaning: Actor Stanley Aughtry Redefines Legacy in Hollywood and Beyond
• Durex Products Wire Cloth Screen Media: Engineered for Maximum Performance and Durability

The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.

The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.

More on EntSun News

• OPRAH.COM Featured Award-Winning Novel AS FAR AS YOU GO BEFORE YOU HAVE TO COME BACK now Available as Audiobook
• How Kallie Boxell Helps Texas Companies Solve the Talent Equation
• KeysCaribbean Vacation Home Rentals Offers Last-Minute Booking Discount of 15 Percent
• purelyIV Blog Named One of the Top 45 IV Therapy Blogs by Feedspot
• purelyIV Launches Mobile Iron Infusion Therapy for Patients with Iron Deficiency Anemia

The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation

For further information about the product or study, please contact:

Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com